DESolve Post-Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT02013349
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT02013349
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, Italy, Jordan
- Registry status
- Completed
Technical summary
Registry record NCT02013349. Allocation not applicable; no masking; primary purpose treatment. Start 2014-04-22 (actual); primary completion 2015-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DESolve Post-Approval Study
- Condition
- Coronary Artery Disease
- Intervention (Device)
- coronary intervention
- Lead sponsor
- Elixir Medical Corporation
Record details
- Record id
cardio:ct-nct02013349- Content hash
38dddc980be35328be7bc971393bc1d7370235be48fb6155249f278c39febdb6